Social media

ICON is pleased to announce its participation in the PHUSE Single Day Event taking place on 7 November in Bloemfontein, South Africa. The event will bring together professionals from across the clinical data science comm...

Clinical trials generate more data than ever. ICON’s new blog reveals how technology—from central monitoring to predictive analytics—makes risk-based quality management more agile, efficient and focused. Discover how sma...

Clinical trials generate more data than ever. ICON’s new blog reveals how technology—from central monitoring to predictive analytics—makes risk-based quality management more agile, efficient and focused. Discover how...

At ICON, career growth is built on curiosity, drive, and determination. Christopher Maguire, Director of Finance Business Partnering, has progressed through six roles in eight years, with each role offering new challen...

At ICON, career growth is built on curiosity, drive, and determination. Chris Maguire, Director of Finance Business Partnering, has progressed through six roles in eight years, with each role offering new challenges, ne...

ICON is proud to be at ISPOR Europe 2025 in Glasgow. Let’s talk about: - Health economics & outcomes research - Real-world evidence - Patient-centred value strategies Together, we can power value and access in healthca...

ICON is proud to be at ISPOR Europe 2025 in Glasgow. Let’s talk about: - Health economics & outcomes research - Real-world evidence - Patient-centred value strategies Together, we can power value and access in healthca...

In this new blog series, we review ISO 14971 (Application of risk management to medical devices) - its history, the principles embedded within it and how it relates to other standards and regulation. For the first editio...

In this new blog series, we review ISO 14971 (Application of risk management to medical devices) - its history, the principles embedded within it and how it relates to other standards and regulation. For the first editio...

Meet ICON experts at the AASLD to learn how ICON partners with sponsors, investigators, patients and other collaborators to deliver strategic, data-driven solutions for MASH and hepatology studies. https://ow.ly/9QBn50X8...

Meet ICON experts at the AASLD to learn how ICON partners with sponsors, investigators, patients and other collaborators to deliver strategic, data-driven solutions for MASH and hepatology studies. https://ow.ly/szmf50X8...

Digital measures, including digital biomarkers and digital endpoints, offer sponsors powerful ways to assess treatment effect in real time, in the real world. But to be meaningful, those measures must be carefully selec...